Dr. Shyam Prabhakant Mani, MD

Dr. Mani practices at Leonard J. Chabert Medical Center in Houma, Louisiana, part of Ochsner Health System.

Dr. Mani's NPI, 1780029645, was assigned on May 6, 2013. Dr. Mani holds Louisiana license 303437.

Dr. Mani's primary practice is Leonard J. Chabert Medical Center, at 1978 Industrial Blvd, Houma, LA 70363 in Terrebonne Parish. The practice phone is (985) 873-2200.

Dr. Mani's primary practice is Leonard J. Chabert Medical Center in Houma, Louisiana, part of Ochsner Health System. Dr. Mani is also affiliated with Terrebonne General Health System. The medical group on file is South Louisiana Medical Associates. Dmand AI also links Dr. Mani to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mani practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Mani's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Mani is licensed in Louisiana.

CMS data shows 70 Medicare services from Dr. Mani across 2 procedure codes in 2024, all of them office visits, for 39 Medicare patients. Medicare paid $5,777 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 39 Medicare patients who saw Dr. Mani in 2024. The largest group is under 65, with 13 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 51% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mani's median patient age at 64, with 63% women.

In 2024, Dr. Mani wrote 534 Medicare Part D claims for 95 patients. 82% of them were for generic drugs. CMS names the drug for 274 of them, across 12 drugs with 11 or more claims each, at $338,039 in total drug cost. In 2023, CMS named 114 claims across 7 drugs.

Dr. Mani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 47 general payments to Dr. Mani from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. AstraZeneca Pharmaceuticals LP paid the most, $217.